Related Experiment Video

Updated: Mar 8, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.8K

Development of a peer-review framework for cancer multidisciplinary meetings

Claire E Johnson1, Neli Slavova-Azmanova1, Christobel Saunders1

  • 1School of Surgery, The University of Western Australia, Perth, Western Australia, Australia.

Internal Medicine Journal
|January 21, 2017
PubMed
Abstract

Insights

A new adaptable peer-review framework was developed to improve cancer multidisciplinary meetings (MDM) in Australia. This quality improvement tool can be modified with disease-specific evidence for broader use.

Area of Science:

  • Oncology
  • Healthcare Quality Improvement
  • Clinical Governance

Background:

  • Cancer multidisciplinary meetings (MDM) in Australia currently lack a formal monitoring or quality improvement mechanism.
  • The need for structured quality assurance in cancer care delivery is critical.

Purpose of the Study:

  • To develop and refine a peer-review process for enhancing the quality of cancer multidisciplinary meetings (MDM).

Main Methods:

  • A three-phase approach was employed: framework development, stakeholder consultation, and a pilot study with three MDMs.
  • The framework and processes were refined based on feedback and pilot study results.

Main Results:

  • Stakeholders emphasized the need for flexibility in peer-review standards based on individual MDM circumstances.
  • Clear, evidence-based guidelines and objective performance measures are required for MDM conduct.
  • Closer involvement of the reviewed MDM team in implementing recommendations is crucial.

Conclusions:

  • An adaptable peer-review framework and process for MDMs were successfully developed using existing evidence.
  • This structured peer-review process, when tailored with disease-specific evidence, can serve as a valuable quality improvement tool.
  • Further research is needed to define best practices in MDM and their impact on patient outcomes.
Keywords:
accreditationmultidisciplinary cancer caremultidisciplinary team meetingspeer reviewquality improvement

More Related Videos

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection10:02

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Published on: December 19, 2025

635
Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication07:47

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Published on: December 15, 2023

1.3K

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
807
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K